Statistical considerations for noninferiority/equivalence trials in vaccine development.
about
Randomized controlled trial of two dosing schedules for human papillomavirus vaccination among college age males.Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3.Phase III, randomized controlled trial in girls 9-15 years old to evaluate lot consistency of a novel nine-valent human papillomavirus L1 virus-like particle vaccine.Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study.Vaccines: A review of immune-based interventions to prevent and treat disease.Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidence.Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial.A dynamic power prior for borrowing historical data in noninferiority trials with binary endpoint.9-Valent human papillomavirus vaccine: a review of the clinical development program.
P2860
Q33724329-C7523454-0638-4521-8187-DE19BCCE9F2CQ35220326-8BE95D52-48FD-44CB-8433-5D8E0E5A882AQ35887777-20E86501-2D36-40BC-BFAE-B53BAB56DA8EQ37710523-C65D72F3-E30D-4DDD-AB61-3F66422EA311Q38364468-7C6BEC4C-1EE8-48DC-AD71-C746AB06ECC5Q39265001-2D38BC96-1CEF-4C74-B726-D70D9BEC28A3Q41654386-5ECF3FFD-0F19-4869-B157-E3B29B93723DQ47618884-01D63003-8730-4D34-8918-78C8CBA70915Q49687633-0F4C570D-C2B6-4F37-909D-02FE039471A8
P2860
Statistical considerations for noninferiority/equivalence trials in vaccine development.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Statistical considerations for noninferiority/equivalence trials in vaccine development.
@ast
Statistical considerations for noninferiority/equivalence trials in vaccine development.
@en
type
label
Statistical considerations for noninferiority/equivalence trials in vaccine development.
@ast
Statistical considerations for noninferiority/equivalence trials in vaccine development.
@en
prefLabel
Statistical considerations for noninferiority/equivalence trials in vaccine development.
@ast
Statistical considerations for noninferiority/equivalence trials in vaccine development.
@en
P2093
P2860
P1476
Statistical considerations for noninferiority/equivalence trials in vaccine development.
@en
P2093
P2860
P304
P356
10.1080/10543400600719251
P577
2006-01-01T00:00:00Z